Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Tissue plasminogen activator (tPA) is a serine protease enzyme that catalyzes the conversion of plasminogen to plasmin, the primary enzyme responsible for dissolving blood clots. It plays a crucial role in fibrinolysis and is used therapeutically to treat acute ischemic events like stroke, myocardial infarction, and pulmonary embolism. tPA's activity is tightly regulated by inhibitors like PAI-1, and its therapeutic use carries risks of bleeding.
Converts plasminogen to plasmin, leading to fibrin clot dissolution.
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Tissue Plasminogen Activator (tPA).